Karleigh A Hamblin Selected Research

Vaccines

1/2014	The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy.
5/2013	Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karleigh A Hamblin Research Topics

Disease

5	Infections 01/2019 - 04/2013
3	Tularemia 07/2019 - 05/2013
1	Alcoholism (Alcohol Abuse) 07/2019
1	Melioidosis 01/2017
1	Plague (Bubonic Plague) 01/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2014
1	Bronchiectasis 01/2014
1	Pseudomonas Infections 01/2014

Drug/Important Bio-Agent (IBA)

4	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2017 - 01/2014
2	finafloxacinIBA 01/2019 - 01/2017
2	chemotactic factor inactivatorIBA 01/2017 - 06/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 04/2013
2	VaccinesIBA 01/2014 - 05/2013
1	Disulfiram (Antabuse)FDA Link 07/2019
1	FluoroquinolonesIBA 01/2019
1	AerosolsIBA 06/2014
1	Liposomes (Liposome)IBA 01/2014
1	CathelicidinsIBA 05/2013

Therapy/Procedure

4	Therapeutics 07/2019 - 05/2013